Assay Development
Flexibility is a key feature of BBInternational’s assay development services. Our fully phased approach allows our customers to assess feasibility/ proof of principle prior to committing to a full scale development programme. This is particularly useful when preliminary data and prototypes are required for grants or funding applications.
Throughout the development of your assay a dedicated and experienced team of scientists works on your product alone. We are able to develop your assay on our range of existing off the shelf platforms or your choice of new novel platforms available on the market. At the end of the development process we hand over the case history so that you ‘own’ your own test, a service offering unique to BBI.
When you choose to outsource development to BBI, you can be sure that we’ll work with you through every step of the development process. Our excellent customer communication practices and regular project updates allow us to share our knowledge with your team, and provide advice and training on all aspects of lateral flow development.
Our skill set includes:
- All assay formats, antibody or antigen sandwich, competitive, quantitative tests/readers and multi-analyte experience
- Development of two fully quantitative devices
- Conversion of EIA’s to rapid tests
- All forms of sample matrix
- Assay design to ensure robust R2R manufacture
- Ab/Ag purification: FPLC, HPLC, Affinity, fragmentation, size exclusion
- Conjugation: colloid, latex, fluorescence
- Hapten manufacture
- Recombinant Ab experience
- Assay Robustness, FMEA, Reduced Factorial Experimental Design
BBI’s assay development service has been set out in stages in order to offer complete flexibility and accountability to each customer’s individual needs.
A typical development programme will involve a 12-24 month timescale and will work as follows:
.jpg)
Please contact us to discuss your development needs.